VCU Stravitz-Sanyal Institute for Liver Disease
@VCU_Liver
The Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at VCU is revolutionizing global health through innovative liver research. 804-828-5066.
ID:1646582754597896209
https://liverinstitute.medschool.vcu.edu/ 13-04-2023 18:35:16
723 Tweets
381 Followers
424 Following
It’s #HepatitisAwarenessMonth ! Make sure your community health partners have the most up-to-date recommendations on #HepatitisC screening and #HepatitisB vaccination: bit.ly/3svyHyV.
Hey #PHPeeps Join us to learn about #Cirrhosis #PulmonaryHypertension and Liver Transplantation w/ Jared Dyer, DO
June 3, 2024
12pm EST
Join via zoom: vcuhealth.zoom.us/j/6953971186?p…
Earn CME!
VCU PCCM Fellowship UVA PCCM Inova VCU Health VCU Stravitz-Sanyal Institute for Liver Disease
If you have #cirrhosis , why not skip the grilled hamburger 🍔 this #MemorialDay weekend? Do your #liver some good. Chow down instead on a vegan or bean burger. Find out why this is a recipe for health success: bit.ly/4dp7fM0 #liver twitter Jasmohan Bajaj
It'll soon be fun in the sun season, so as you think about your diet and nutrition, don't forget about eating for your liver. bit.ly/41Kcnnz #LiverTwitter #liver #HealthyEating
New study led by VCU Massey Comprehensive Cancer Center's Devanand Sarkar determined that a specific mutation exhibits zone-specific differential gene expression, which might contribute to the onset of HCC. Via Journal of Biological Chemistry #livertwitter bit.ly/4bOuGMV
Our CCO, Richard Sterling (rear, right), is having way too much fun at #DDW2024 , with physicians Guadalupe Garcia-Tsao (front, left), Elizabeth Verna (front, right), Cynthia Levy (rear, left), and Sumeet Asrani, (rear, middle). A fine demonstration of collegiality. #livertwitter
Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with NAFLD. Thanks to a great group of leaders and NASH CRN colleagues, including our @Saulkarpen. bit.ly/3KazG2L #livertwitter
At #DDW2024 , Naim Alkhouri spoke with @hcplive on Interim Analysis of Phase 2 Survodutide Data Show Promise for MASH, Fibrosis. More details to come in Milan at #EASLCongress . bit.ly/3ULhzoW #livertwitter Digestive Disease Week Arun J. Sanyal
NOW with the URL. 😉 At Digestive Disease Week, Richard Sterling reviewed the new AASLD practice guidelines advising how and when to use blood-based and imaging tests for #fibrosis and #steatosis . #DDW2024 #livertwitter bit.ly/4dQNYD7
The results of the interim analysis of Survodutide for MASH w fibrosis were presented today at Digestive Disease Week . 🔑 findings: 1. Up to 90% decreased liver fat by > 30%. 2. Great reduction in ALT/ AST. Great reduction in ELF. The future is bright Mazen Noureddin, MD, MHSc VCU Stravitz-Sanyal Institute for Liver Disease Ramy Younes, MD, PhD g
At Digestive Disease Week, Richard Sterling reviewed the new AASLD practice guidelines advising how and when to use blood-based and imaging tests for #fibrosis and #steatosis . #DDW2024 #livertwitter
Wonderful AASLD #ETC on #microbiome in liver disease. 🙏Cristina Llorente & Suthat Liangpunsakul for this in depth symposium. Free exchange of ideas & collaborations! #DDW2024
May is Hepatitis Awareness Month in the U.S., and Sunday, May 19, is Hepatitis Testing Day. If left untreated, hepatitis can turn into #liver cancer. Get tested. Learn about treatments, prevention and management of the virus. #HepCantWait #LiverHealthisPublicHealth #liver twitter